- Home
- /
- Treatment
- /
- Page 27
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Antisense oligonucleotide inhibitor of the expression of superoxide dismutase 1 gene | Amyotrophic lateral sclerosis | Biogen;225 Binney Street;Cambridge, Massachusetts, 02142 | September 19, 2016 | |
Decitabine and tetrahydrouridine | Sickle cell anemia | EpiDestiny Inc.;7536 Royal Portrush Drive;Solon, Ohio, 44139 | September 19, 2016 | |
3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione hydrochloride | Diffuse Large B-cell Lymphoma | Celgene Corporation;400 Connell Drive, Suite 7000;Berkeley Heights, New Jersey, 07922 | September 19, 2016 | |
Methylprednisolone oral suspension | Adrenal insufficiency in pediatric patients | Generic Specialty Pharma;Unit 10, Block 3, City North Business Campus;Stamullin | September 19, 2016 | |
ProTmune (ex vivo Programmed Mobilized Peripheral Blood) | Graft Versus Host Disease | Fate Therapeutics;3535 General Atomics Court, Suite 200;San Diego, California, 92121 | September 19, 2016 | |
Fixed dose combination of modafinil and flecainide | Narcolepsy | Theranexus S.A;86 Rue de Paris;Orsay | September 19, 2016 | |
Disulfide-stabilized single-chain variable region fragment of the anti-EGFR wild type/EGFRvIII dual specificity monoclonal antibody with variable fragments fused to a truncated version of the Pseudomonas exotoxin A, PE38, and KDEL | Glioma | Darell D. Bigner, MD, PhD;Duke University Medical Center, Oreuss Laboratory -Brain Tumor Research;Durham, North Carolina, 27710 | September 19, 2016 | |
Recombinant adeno-associated virus serotype rhesus 74 expressing the human dysferin gene (AAVrh74.MHCK7.DYSF.DV) | Limb-girdle muscular dystrophy- type 2B | Nationwide Children's Hospital;700 Children's Drive, Rm WA2025;Columbus, Ohio, 43205 | September 19, 2016 | |
Riluzole oral suspension | Amyotrophic lateral sclerosis | Italfarmaco SpA;54 Via dei Lavoratori;Cinisello Balsamo | September 15, 2016 | |
Emodepside | Onchocerhiasis ("river blindness") caused by the filarial nematode onchocerca volvulus | Bayer HealthCare Pharmaceuticals, Inc.;100 Bayer Boulevard, P. O. Box 915;Whippany, New Jersey, 07981 | September 13, 2016 | |
Poly(lactide-co-glycolide) carboxylated microparticle | Malaria | Cour Pharmaceutical Development Company, Inc.;428 S. Hillside Avenue;Elmhurst, Illinois, 60126 | September 13, 2016 | |
Terlipressin | Ascites due to all etiologies except cancer | Bio Vie Inc.;100 Cummings Center, Suite 247-C;Beverly, Massachusetts, 01915 | September 8, 2016 | |
Coversin; rEV675 | Hemoglobinuria | Akari Therapeutics Plc;24 West 40th Street, 8th Floor;New York, New York, 10018 | September 8, 2016 | |
Autologous CD4+/CD8+ T cells expressing a CD19 chimeric antigen receptor and a truncated epidermal growth factor receptor | Acute lymphoblastic leukemia | Juno Therapeutics, Inc.;400 Dexter Avenue North, Suite 1200;Seattle, Washington, 98109 | September 7, 2016 | |
6-fluoro-(18F)-L-3,4-dihydroxyphenylalanine | A diagnostic for management of patients with Lesch-Nyhan syndrome | Advanced Imaging Projects, LLC;7947 Brookside Ct.;Lake Worth, Florida, 33467 | September 7, 2016 | |
Brentuximab vedotin | Primary cutaneous CD30-positive T-cell lymphoproliferative disorders | Seattle Genetics, Inc.;21823 30th Drive Southeast;Bothell, Washington, 98021 | September 7, 2016 | |
Rituximab and recombinant human hyaluronidase | Diffuse Large B-cell Lymphoma | Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 | September 7, 2016 | |
Cinacalcet | Focal segmental glomerulosclerosis | Amgen, Inc.;One Amgen Center Drive, Bldg 17, 1A-4-4, Mail Stop 17-1-B;Thousand Oaks, California, 91320 | September 7, 2016 | |
Mesylate synthetic small molecule inhibitor of HDAC and PI3K | Nuclear protein in testis (NUT) midline carcinoma | Curis, Inc.;4 Maguire Road;Lexington, Massachusetts, 02421 | September 6, 2016 | |
Cisplatin | Anal cancer | Privo Technologies;13 Bristol Street, Unit #1;Cambridge, Massachusetts, 02141 | September 6, 2016 | |
Bilayer, engineered collagen hydrogel-based skin graft composed of autologous keratinocytes and fibroblasts | Partial deep dermal and full thickness burn wounds | University Children's Hospital Zurich;Tissue Biology Research Unit, 7 August-Forel-Strasse;Z�rich | September 6, 2016 | |
4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol | Angelman syndrome | Ovid Therapeutics;1460 Broadway;New York, New York, 10036 | September 6, 2016 | |
Recombinant adeno-associated virus vector serotype 9 expressing human iduronate-2-sulfatase | Hunter Syndrome | Research Institute at Nationwide Children's Hospital;Center for Gene Therapy, 700 Childrens Drive;Columbus, Ohio, 43205 | September 1, 2016 | |
Recombinant adeno-associated virus vector serotype 9 expressing human N-Sulfoglucosamine Sulfohydrolase | Sanfilippo Syndrome | Research Institute at Nationwide Children's Hospital;Center for Gene Therapy, 700 Childrens Drive;Columbus, Ohio, 43205 | September 1, 2016 | |
Adeno-associated virus serotype 2/6 (rAAV2/6) vectors encoding zinc finger nucleases (ZFNs) and human factor 9 gene (SB-FIX) | Hemophilia B | Sangamo Therapeutics, Inc.;Point Richmond Tech Center, 501 Canal Boulevard;Richmond, California, 94804 | September 1, 2016 |